<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00448968</url>
  </required_header>
  <id_info>
    <org_study_id>IMA-0806-003</org_study_id>
    <nct_id>NCT00448968</nct_id>
  </id_info>
  <brief_title>The Utility of Ischemia Modified Albumin (IMA) in Sepsis</brief_title>
  <official_title>The Utility of Ischemia Modified Albumin (IMA) in Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Inverness Medical Innovations</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Inverness Medical Innovations</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if levels of ischemia modified albumin (IMA) in&#xD;
      blood are elevated in patients with suspected infection and are predictive of severity of&#xD;
      illness in patients with sepsis.&#xD;
&#xD;
      In order to compare subjects with infection to those without infection who are representative&#xD;
      of the ED population at each site, a group of non-infected control patients will be enrolled.&#xD;
      Each hospital will enroll subjects with age (by decade) and sex matched controls to reflect&#xD;
      the population of subjects suspected of infection.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sepsis is an unconquered challenge in medicine, affecting people of all ages and&#xD;
      demographics. Severe sepsis affects approximately 751,000 patients in the United States per&#xD;
      annum, with healthcare costs approaching $16.7 billion dollars a year. Mortality from severe&#xD;
      sepsis and septic shock approaches 30 - 70 % with 215,000 deaths annually. Thus, sepsis is a&#xD;
      disease with healthcare dollars and mortality rates approaching those of heart disease and&#xD;
      cancer.&#xD;
&#xD;
      Identifying patients with sepsis, and in particular hypoperfusion, is a challenge to the&#xD;
      clinician. A variety of clinical and laboratory findings are helpful, but there is no single&#xD;
      test to identify sepsis or assess its severity.&#xD;
&#xD;
      Ischemia and reactive oxygen species play a significant role in the pathogenesis of sepsis.&#xD;
      Moreover, there is evidence to suggest that septic shock results in dysfunction of&#xD;
      autoregulatory mechanisms and misdistribution of blood flow, precipitating both regional and&#xD;
      global ischemia. A method that can help rapidly assess hypoperfusion would be clinically&#xD;
      useful. Ischemia modified albumin (IMA) is a potential marker for ischemia in acute coronary&#xD;
      syndrome patients; thus, it is hypothesized that IMA may be also useful as a prognostic&#xD;
      biomarker for clinical identification of infection and the severity of illness in patients&#xD;
      with sepsis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">September 2007</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <enrollment type="Actual">150</enrollment>
  <condition>Sepsis</condition>
  <condition>Severe Sepsis</condition>
  <condition>Systemic Inflammatory Response Syndrome</condition>
  <condition>Sepsis Syndrome</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria for Sepsis Subjects:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Able to provide informed consent&#xD;
&#xD;
          -  Clinical suspicion of infection&#xD;
&#xD;
        Exclusion Criteria for Sepsis Subjects:&#xD;
&#xD;
          -  Active chest pain of suspected cardiac origin&#xD;
&#xD;
          -  ST elevation myocardial infarction or dynamic ST changes on EKG&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Cocaine use&#xD;
&#xD;
          -  Liver disease&#xD;
&#xD;
          -  Unable to speak or understand the English language&#xD;
&#xD;
        Inclusion Criteria for Control Subjects:&#xD;
&#xD;
          -  18 years of age or older&#xD;
&#xD;
          -  Emergency Department presentation as a result of a non-infectious etiology as&#xD;
             determined by the treating clinicians&#xD;
&#xD;
          -  Able to provide informed consent&#xD;
&#xD;
        Exclusion Criteria for Control Subjects:&#xD;
&#xD;
          -  Suspected Infection&#xD;
&#xD;
          -  Temperature &gt;100.4Â°F&#xD;
&#xD;
          -  Pregnant women&#xD;
&#xD;
          -  Possible cardiac, intestinal or cerebral ischemia&#xD;
&#xD;
          -  Liver disease&#xD;
&#xD;
          -  Any source of inflammation as part of their presentation&#xD;
&#xD;
          -  cancer, any type&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nathan Shapiro, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deaconess Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Munish Goyal, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rakesh Engineer, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinc</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania School of Medicine</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2007</verification_date>
  <study_first_submitted>March 16, 2007</study_first_submitted>
  <study_first_submitted_qc>March 16, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 19, 2007</study_first_posted>
  <last_update_submitted>September 26, 2007</last_update_submitted>
  <last_update_submitted_qc>September 26, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 27, 2007</last_update_posted>
  <keyword>Sepsis</keyword>
  <keyword>Ischemia Modified Albumin</keyword>
  <keyword>Systemic Inflammatory Response Syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Systemic Inflammatory Response Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

